Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
Absci Corp (BSCI) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/17/2023 8-K Quarterly results
08/14/2023 8-K Quarterly results
Docs: "Absci Reports Business Updates and Second Quarter 2023 Financial and Operating Results Entered into partnership with Google Ventures-backed biotech company to discover innovative new medicines",
"Absci Appoints Zach Jonasson, Ph.D., as Chief Financial Officer and Chief Business Officer Addition of veteran biotech leader to further support Absci’s next stage of growth"
06/16/2023 8-K Entry into a Material Definitive Agreement, Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Submiss...
Docs: "ABSCI CORPORATION $100,000,000 COMMON STOCK SALES AGREEMENT",
"AMENDED AND RESTATED CERTIFICATE OF INCORPORATION OF ABSCI CORPORATION",
"3 Embarcadero Center San Francisco, CA 94111"
06/06/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Absci Evolves its Board of Directors with HealthTech Luminary Frans van Houten, Former CEO of Philips"
12/16/2022 8-K Quarterly results
11/09/2022 8-K Quarterly results
11/02/2022 8-K Quarterly results
10/04/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
Docs: "Absci Appoints Veteran Pharma Executive Andreas Busch, PhD as Chief Innovation Officer Dr. Busch transitions from Absci’s Board of Directors to Absci’s Executive Leadership team"
09/20/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/11/2022 8-K Quarterly results
07/14/2022 8-K Quarterly results
06/10/2022 8-K Quarterly results
05/11/2022 8-K Quarterly results
03/22/2022 8-K Quarterly results
Docs: "Absci Reports Full Year 2021 Financial and Operating Results",
"Absci Develops Groundbreaking Machine Learning Models for In-Silico Antibody Design, Powered by NVIDIA Absci to present in-silico drug discovery technology at NVIDIA GTC"
03/21/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/10/2022 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
01/07/2022 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "Absci Announces Research Collaboration with Merck Collaboration to leverage Absci’s Deep Learning-Enabled Drug Creation™ and Bionic Protein™ technologies"
11/09/2021 8-K Quarterly results
Docs: "Absci Reports Third Quarter 2021 Financial and Operating Results"
09/07/2021 8-K Quarterly results
08/24/2021 8-K Quarterly results
07/26/2021 8-K Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits
Docs: "Amended and Restated Certificate of Incorporation of Absci Corporation",
"Amended and Restated Bylaws of Absci Corporation"

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy